Using the Medication Adherence Reasons Scale (MAR-Scale) to identify the reasons for non-adherence across multiple disease conditions

References

• World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva; World Health Organization; 2003.
   Google Scholar
• Grahame-Smith D, Aronson J. Oxford Textbook of Clinical Pharmacology and Drug Therapy. 3rd ed. USA: Oxford University Press; 2002.
   Google Scholar
• New England Health Care Institute. Thinking outside the pillbox: a system-wide approach to improving patient medication adherence for chronic disease; 2009 https://www.nehi.net/writable/publication_files/file/pa_issue_brief_final.pdf. Accessed 1020, 2018.
   Google Scholar
• Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26:331–342.11679023
   PubMed Web of Science ®Google Scholar
• DiMatteo MR. Variations in patients‘ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–209.15076819
   PubMed Web of Science ®Google Scholar
• Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38:303–312. doi:10.1345/aph.1D25214742770
   PubMed Web of Science ®Google Scholar
• Horne R. Patients‘ beliefs about treatment: the hidden determinant of treatment outcome? J Psychosom Res. 1999;47(6):491–495.10661596
   PubMed Web of Science ®Google Scholar
• Nguyen TM, La Caze A, Cottrell N. What are validated self-report adherence scales really measuring? A systematic review. Br J Clin Pharmacol. 2014;77(3):427–445. doi:10.1111/bcp.1219423803249
   PubMed Web of Science ®Google Scholar
• Unni EJ, Farris KB. Development of a new scale to measure self-reported medication nonadherence. Res Soc Adm Pharm. 2015;11(3):e133–e143. doi:10.1016/j.sapharm.2009.06.005
   Web of Science ®Google Scholar
• Unni EJ, Olson JL, Farris KB. Revision and validation of Medication adherence reasons scale (MAR-SCALE). Curr Med Res Opin. 2014;30(2):211–221. doi:10.1185/03007995.2013.85107524102296
   PubMed Web of Science ®Google Scholar
• Bolge SC, Doan JF, Kannan H, Baran RW. Association of insomnia with quality of life, work productivity, and activity impairment. Qual Life Res. 2009;18(4):415–422.19288223
   PubMed Web of Science ®Google Scholar
• Finkelstein EA, Allaire BT, DiBonaventura MD, Burgess SM. Direct and indirect costs and potential cost savings of laparoscopic adjustable gastric banding among obese patients with diabetes. J Occup Environ Med. 2011;53(9):1025–1029.21866052
   PubMed Web of Science ®Google Scholar
• Gupta S, Richard L, Forsythe A. The humanistic and economic burden associated with increasing body mass index in the EU5. DiabetesMetab Syndr Obes. 2015;8:327–338.
   Web of Science ®Google Scholar
• Gupta S, Ryvlin P, Faught E, Tsong W, Kwan P. Understanding the burden of focal epilepsy as a function of seizure frequency in the United States, Europe, and Brazil. Epilepsia Open. 2017; 2(2): 199–21329588949
   PubMedGoogle Scholar
• Gruenberger J, Vietri J, Keininger D, Mahler D. Greater dyspnea is associate with lower health-related quality of life among European patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017; 12: 937–944.28360517
   PubMed Web of Science ®Google Scholar
• Gupta S, Kwan P, Faught E, Tsong W, Forsythe A, Ryvlin P. Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey. Epilepsy Behav. 2016; 55:146–156.26773686
   PubMed Web of Science ®Google Scholar
• Gupta S, Isherwood G, Jones K, Van Impe K. Assessing health status in informal schizophrenia caregivers compared with health status in non-caregivers and caregivers of other conditions. BMC Psychiatry. 2015;15(162) : 1–12.25609320
   PubMed Web of Science ®Google Scholar
• Pavord I, Mathieson N, Scowcroft A, Pedersini R, Isherwood G, Price D. The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis. NPJ Prim Care Respir Med 2017; 27(1):17 : 1–9.
   Google Scholar
• Yurdugul H. Minimum sample size for Cronbach’s coefficient alpha: a Monte Carlo study. H U J Edcn. 2008;35:397–405.
   Google Scholar
• Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113–124. doi:10.1016/S0738-3991(98)00107-414528539
   PubMed Web of Science ®Google Scholar
• Kripalani S, Risser J, Gatti ME, et al. Development and evaluation of the Adherence to refills and medications scale (ARMS) among low-literacy patients with chronic disease. Value Health. 2009;12:118–123. doi:10.1111/j.1524-4733.2008.00400.x19911444
   PubMed Web of Science ®Google Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74. doi:10.1097/00005650-198601000-000073945130
   PubMed Web of Science ®Google Scholar
• Hahn SR, Park J, Skinner EP, et al. Development of the ASK-20 adherence barrier survey. Curr Med Res Opin. 2008;24:2127–2138. doi:10.1185/0300799080217476918554431
   PubMed Web of Science ®Google Scholar
• McHorney CA. The adherence estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin. 2009;25:215–237. doi:10.1185/0300799080261942519210154
   PubMed Web of Science ®Google Scholar